D/M/O

SUBSCRIBE
SEARCH

Everything You Need to Know About Taglich Brothers Inc.

November 22, 2017

|

Steven Lachard

 

Readers that follow analyst upgrades and downgrades on cannabis stocks are used to seeing coverage from analysts and firms like Canaccord Genuity's Matt Bottomley, Cowen & Co's Phil Nadeau and more. Following the recent research report from Taglich Brothers' John Nobile regarding Solis Tek (OTC:SLTK), many readers have asked us for more information about the firm that issued it. 

 

Background on Taglich Brothers, Inc.

 

For starters, Huntington, New York based Taglich Brothers, Inc. was founded in 1991 and is now a full service brokerage firm specializing in the publicly listed microcap securities.

 

While the Taglich name is mainly known for its focus on microcap stocks, those in the private equity world may have heard the name from its partner, Taglich Private Equity LLC. The firm has also hosted an annual investment conference for 14 years, with its upcoming 15th Annual Taglich Brothers 2018 Investment Conference on the horizon.

 

Taglich Brothers Research

 

 

Aside from its coverage of Solis Tek, Taglich Brothers, Inc. has also issued recent research reports on companies including:

  • MamaMancini's Holdings, Inc. (OTC:MMMB)

  • Zynex, Inc. (OTC:ZYXI)

  • Poydras Gaming Finance Corp. (TSXV:PYD) (OTC:PYDGF)

  • MDxHealth SA (OTC:MXDHF)

  • UFP Technologies, Inc. (NASDAQ:UFPT)

  • Trxade Group, Inc. (OTC:TRXD)

  • and more...

 

Taglich Brothers Investment Banking

 

 

Taglich Brothers' investment banking group specializes in private placements of equity and debt, capital formation, restructuring and re-capitalizations. Some of their recent transactions include the placement of $2,000,000 in convertible preferred shares of Bridgeline Digital (NASDAQ:BLIN), and the arrangement of financing for the acquisition of Marth Companies LLC by Lignetics. 

 

Taglich Private Equity

 

While the broker-dealer side of the firm recently began coverage of a cannabis cultivator-focused lighting company, Taglich Private Equity has nothing to do with cannabis. The portfolio consists of both public and private companies.

 

The firm's public portfolio includes Air Industries Group (NYSE:AIRI), BG Staffing Inc. (NYSE:BGSF), Orchids Paper Products Company (NYSE:TIS), and more. 

 

The firm's current private portfolio includes companies like Private Label Skin, Pinnacle Climate Technologies, Simkar Corporation and more.  

 

Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, YouTube, and Instagram.

 

D/M/O

Read more articles tagged:

Taglich Brothers, Inc.

Taglich Private Equity LLC

New York

Please reload

BREAKING NEWS

50 Blue Chip Stocks Worth Less than Half as Much a...

September 19, 2018

5 of Today's Biggest Marijuana Stock Losers -...

September 10, 2018

5 of Today's Biggest Marijuana Stock Gainers -...

September 5, 2018

5 of Today's Biggest Marijuana Stock Losers -...

September 5, 2018

5 of Today's Biggest Marijuana Stock Gainers -...

September 4, 2018

5 of Today's Biggest Marijuana Stock Losers -...

September 4, 2018

Aphria Partners with Danish Flower Producer

September 4, 2018

Namaste Announces Medical Cannabis Supply Agreemen...

September 4, 2018

Aurora Cannabis Closes $200 Million Debt Facility...

September 4, 2018

5 of Today's Biggest Marijuana Stock Gainers -...

August 30, 2018

Please reload

  • Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Taglich Brothers Assigns 'Buy' Rating to Solis Tek, Sees >100% Upside

November 21, 2017

Canaccord Initiates Coverage, Issues 'Speculative Buy' Rating on MedReleaf

November 2, 2017

Needham Issues 'Buy' Rating on Cara Therapeutics, Sees >85% Upside

October 19, 2017

GMP Securities Assigns 'Hold' Rating on Aphria, Sees >18% Upside

October 19, 2017

Marijuana Investments: Private Placements vs. Public Listings

August 8, 2017

Cannabis-Focused Private Equity Firms Worth Watching

February 28, 2017

1/1
Please reload

  • HOME

  • WORLD

  • U.S.

  • STOCKS

  • LEGAL

  • LIFESTYLE

  • TV

  • DATABASES

  • FORUMS

  • MORE

  • MORE

    GO PRO

    • Daily Marijuana Observer Facebook
    • Daily Marijuana Observer Twitter
    0

    About

    Authors

    Contact

    Careers

    Subscribe

    Marijuana Stock Database

    Website Help Center

    DMO

    © Copyright 2016-2018 Smoke Show Ventures, Inc.

    Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.

    RSS Feed